MariaMillanMD

General Surgery • Oakland, CA

Hepatobiliary Surgery, Pancreas, Transplantation

President & CEO CIRM

Join to view full profile

Dr. Millan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Millan's full profile

Already have an account?

Office
CIRM- Lake Merrit Plaza
1999 Harrison St.
Oakland, CA 94612
Phone+1 415-205-7968
Is this information wrong?

Summary

Changing the face of medicine – the CIRM 2018 Annual Report
https://www.cirm.ca.gov/about-cirm/2018-annual-report

Cell Stem Cell - Profile on Maria Millan as the new President of. CIRM

Unite To Cure: Maria T. Millan, MD

Maria Millan reflects on a papal address in 2000 by Pope John Paul II and how Pope Francis's address to #UniteToCure echoed the potential of stem cell medicine

San Francisco Chronicle

As part of our in-depth series on stem cells, Chronicle health reporter Erin Allday interviews Maria Millan, president of the California Institute for Regenerat

Supporting the future of regenerative medicine: an interview with CIRM's Maria M

In this interview, Maria Millan, the new President and CEO of the California Institute for Regenerative Medicine, reflects on CIRM's successes so far and makes

California's Stem Cell Agency

CIRM funds promising stem cell research in California to accelerate stem cell treatments to patients with unmet medical needs.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Abdominal Transplant Surgery, 1998 - 2000
Beth Israel Deaconess Medical CenterResidency, Surgery, 1990 - 1997
Harvard Medical SchoolPost-Doctoral Fellowship, Transplant Immunobiology , 1994 - 1996
Rutgers New Jersey Medical SchoolClass of 1990
Duke UniversityBS, Zoology, Cum laude, 1982 - 1986

Certifications & Licensure

CA State Medical License Active through 2013

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons

Clinical Trials

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Start of enrollment: 2005 Jun 01
Completed
Phase 4

Publications & Presentations

PubMed

46 citations
The duodenal microbiome is altered in small intestinal bacterial overgrowth.
Gabriela Leite, Walter Morales, Stacy Weitsman, Shreya Celly, Gonzalo Parodi, Ruchi Mathur, Gillian M. Barlow, Rashin Sedighi, Maria Jesus Villanueva Millan, Ali Rezai...> ;Plos One. 2020 Jul 9
A pilot investigation of neuroimaging predictors for the benefits from pivotal response treatment for children with autism.
Hegarty, J. P.,Gengoux, G. W.,Berquist, K. L.,Millán, M. E.,Tamura, S. M.,Karve, S.,Rosenthal, M. D.,Phillips, J. M.,Hardan, A. Y.> ;J Psychiatr Res. 2019 Feb 17
163 citations
Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.
Maria T. Millan, Judith A. Shizuru, Petra Hoffmann, Sussan Dejbakhsh-Jones, John D. Scandling, F. Carl Grumet, Jane C. Tan, Oscar Salvatierra, Richard T. Hoppe, Samuel...> ;Transplantation. 2002 May 15

Other

Annual Report
CIRM
https://www.cirm.ca.gov/sites/default/files/files/about_cirm/CIRM%202017%20Annual%20Report_Web.pdf
1/15/2018

Authored Content

SF Chronicle- Interview about Stem Cells8/30/2018

Press Mentions

How CIRM-Funded Research Is Bringing a Lifesaving Gene Therapy to a 5-Year-OldMay 3rd, 2023
Combangio, Inc., a Wholly Owned Subsidiary of Kala Pharmaceuticals, Awarded $15 Million by California Institute for Regenerative Medicine to Support Ongoing KPI-012 Program for the Treatment of PCEDApril 28th, 2023
Making Transplants Easier for Kids, and Charting a New Approach to Fighting Solid TumorsNovember 30th, 2022
Join now to see all